Overview
- 74 inspections across 74 sites are on record.
- 39 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-25.
At a glance
Inspections
74
Sites
74
Observations
39
Career since
Aug 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Musculoskeletal Transplant Foundation | 25 Jun 2026 | Biologics | |
| Central California Blood Center | 24 Apr 2026 | Biologics | |
| Octapharma Plasma Inc | 22 Apr 2026 | Biologics | |
| BioLife Plasma Services L.P. | 20 Apr 2026 | Biologics | |
| Biomat USA Inc | 16 Apr 2026 | Biologics |
Sites inspected
Musculoskeletal Transplant FoundationSyracuse, United States1 insp.
Central California Blood CenterFresno, United States1 insp.
Octapharma Plasma IncFresno, United States1 insp.
BioLife Plasma Services L.P.Fresno, United States1 insp.
Biomat USA IncFresno, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Celeta S Coves8 shared
Emily B Camire3 shared
Yvonne C Wilkes2 shared
Eric Zhu1 shared
Karen J Bak1 shared
Creighton T Tuzon1 shared
Laurissa S Flowers1 shared
Full investigator report
Get the verbatim findings behind Dylan R Jock's 39 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site